Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy

Published:2018-07 Issue:1 Volume:288 Page:26-35
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Wu Jia^ORCID,Cao Guohong,Sun Xiaoli,Lee Juheon,Rubin Daniel L.,Napel Sandy,Kurian Allison W.,Daniel Bruce L.,Li Ruijiang

Funder

National Cancer Institute

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2018172462

Reference45 articles.

1. Preoperative Therapy in Invasive Breast Cancer: Pathologic Assessment and Systemic Therapy Issues in Operable Disease

2. Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

3. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL

4. Addressing overdiagnosis and overtreatment in cancer: a prescription for change

5. Clinical management of breast cancer heterogeneity

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor habitat-based MRI features assessing early response in locally advanced nasopharyngeal carcinoma;Oral Oncology;2024-11

2. Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection;npj Precision Oncology;2024-09-07

3. A clinicopathological-imaging nomogram for the prediction of pathological complete response in breast cancer cases administered neoadjuvant therapy;Magnetic Resonance Imaging;2024-09

4. Tumor habitat and peritumoral region evolution–based imaging features to assess risk categorization of thymomas;Clinical Radiology;2024-09

5. Use of Pretreatment Perfusion MRI–based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy;Radiology;2024-09-01